Two members of Congress are calling on the Food and Drug Administration to overhaul databases providing public information about the safety of medical devices that rarely undergo clinical trials.

Legislation introduced in February, H.R. 3847, would permit FDA to reject an application for a new device if it is modeled after an earlier product that was pulled from the market after causing harm. The bill remains pending in the House of Representatives.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access